High Blood Pressure: Embolic Stroke Risk And Prevention

High blood pressure is a significant risk factor for stroke. In the United States, stroke is a leading cause of death, with more than 795,000 people experiencing a stroke annually. High blood pressure can weaken and narrow the blood vessels, allowing them to become blocked or rupture more easily. An ischemic stroke occurs when a blood clot or fatty deposits block a blood vessel leading to the brain. A hemorrhagic stroke occurs when a blood vessel in the brain ruptures or leaks blood, placing pressure on the brain cells. Therefore, a person with weakened or narrow blood vessels due to untreated high blood pressure has a much higher risk of experiencing a stroke.

High blood pressure can cause arteries to burst or clog

High blood pressure is a leading cause of stroke, which is a leading cause of death and severe, long-term disability. Most people who have had a stroke also had high blood pressure.

High blood pressure damages arteries throughout the body, creating conditions that can make arteries burst or clog easily. Weakened or blocked arteries in the brain create a much higher risk for stroke.

There are two types of strokes: ischemic and hemorrhagic. Ischemic strokes occur when an artery that supplies blood to the brain becomes blocked by a clot. This can happen in two ways: a thrombotic stroke, where the clot forms in a diseased artery within the brain, and an embolic stroke, where the clot forms outside the brain and travels to the brain. Embolic strokes are usually more severe. Thrombotic strokes are more common than embolic strokes.

Hemorrhagic strokes occur when a blood vessel in the brain bursts, spilling blood into the brain or the fluid that surrounds it. Hemorrhagic strokes are less common but often cause more dramatic symptoms.

High blood pressure is the leading cause of strokes, and both systolic and diastolic hypertension contribute to the risk. The higher the blood pressure, the higher the risk of stroke. However, treating hypertension can significantly reduce the risk of stroke.

Lifestyle changes can help reduce the risk of stroke, including eating a nutritious diet, exercising regularly, stopping smoking, and limiting alcohol consumption. Managing existing health conditions such as high blood pressure, diabetes, obesity, heart disease, and high cholesterol can also help lower the risk.

High blood pressure is the leading cause of strokes

High blood pressure damages arteries throughout the body, creating conditions that can make arteries burst or clog easily. Weakened or blocked arteries in the brain create a much higher risk of stroke. This is why managing high blood pressure is critical to reducing the risk of stroke.

There are two major types of strokes: ischemic and hemorrhagic. Hemorrhagic strokes occur when a blood vessel in the brain bursts, spilling blood into the brain or the fluid that surrounds it. Ischemic strokes, which account for about 87% of all strokes, result when an artery that supplies blood to the brain becomes blocked by a clot. This can happen in one of two ways: a thrombotic stroke, where the clot forms in a diseased artery within the brain, or an embolic stroke, where the clot forms outside the brain and then travels to the brain.

High blood pressure increases the risk of both types of strokes. According to a Harvard study, hypertension increases a man's risk of stroke by 220%. Additionally, each 10 mm Hg rise in systolic pressure boosts the risk of ischemic stroke by 28% and hemorrhagic stroke by 38%. Therefore, the higher the blood pressure, the higher the risk of stroke.

However, the good news is that treating high blood pressure can significantly reduce the risk of stroke. Lowering systolic blood pressure by 10 mm Hg can cut the risk of stroke by 44%. Lifestyle changes, such as maintaining a moderate weight, exercising regularly, eating a balanced diet, quitting smoking, and limiting alcohol intake, can also help lower blood pressure and reduce the risk of stroke.

High blood pressure increases the risk of mild cognitive impairment, vascular dementia, and Alzheimer's disease

High blood pressure is a risk factor for vascular cognitive impairment and Alzheimer's disease, the two most common causes of dementia, accounting for 85% of cases. Hypertension causes acute and chronic injury to the brain, accelerating brain atrophy and neuroinflammatory processes, all of which contribute to cognitive impairment and dementia.

High blood pressure affects brain structure and microvasculature, and is a risk factor for other diseases associated with an increased risk of dementia, such as chronic kidney disease and heart failure. Population-level targets to reduce the incidence of dementia are a public health priority. Meta-analyses of blood pressure-lowering trials have shown a significant reduction in the risk of dementia, although the relative and absolute risk reductions are modest. However, given the high lifetime prevalence of both hypertension and dementia, such relative risk reduction would translate into important population-level reductions in dementia globally with effective screening and control of high blood pressure.

High blood pressure can cause cerebral ischemia and haemorrhage, accelerated brain atrophy, cerebral microvascular rarefaction and endothelial dysfunction, disruption of the blood-brain barrier, and neuroinflammation that affects amyloid pathologies. These mechanisms contribute to cognitive decline and increase the risk of mild cognitive impairment, vascular dementia, and Alzheimer's disease.

Vascular dementia is the second most common form of dementia after Alzheimer's disease. It is caused by reduced blood flow to the brain, which deprives brain cells of the oxygen and nutrients they need to function correctly. Brain blood flow can also be affected in Alzheimer's disease, which may further increase the risk of developing the disease. High blood pressure is a significant risk factor for vascular dementia, as it puts extra stress on blood vessels in the brain, increasing the risk of vascular problems.

High blood pressure can cause blood vessels to narrow and weaken

High blood pressure, or hypertension, is a common condition that affects the body's arteries. It occurs when the force of the blood pushing against the walls of the blood vessels is too high. This means the heart has to work harder to pump blood. Over time, high blood pressure can cause damage to the walls of blood vessels, leading to a range of serious health problems.

High blood pressure can cause the blood vessels to narrow and weaken in several ways. Firstly, the excessive pressure on the artery walls can lead to damage and tiny tears in the blood vessels. As the body repairs these tears, substances like cholesterol and fats can build up, forming plaque. This process, known as atherosclerosis, results in the narrowing of the arteries, further increasing blood pressure.

Secondly, high blood pressure can create conditions that make arteries more susceptible to bursting or clogging. Weakened or blocked arteries in the brain significantly increase the risk of stroke. A stroke occurs when a blood vessel to the brain is narrowed or blocked by a clot (ischemic stroke) or bursts (hemorrhagic stroke). High blood pressure is a leading risk factor for stroke, and most people who have had their first stroke also had high blood pressure.

Additionally, high blood pressure can lead to the development of aneurysms. An aneurysm occurs when a blood vessel weakens and bulges outward, forming a balloon-like structure. If left untreated, aneurysms can rupture, leading to life-threatening situations.

Finally, high blood pressure can cause changes in the blood vessels, particularly in the kidneys. This can lead to conditions such as kidney damage and kidney problems.

In summary, high blood pressure can have detrimental effects on blood vessels, causing them to narrow and weaken. This can lead to a range of serious health complications, including stroke, aneurysms, and kidney problems. It is important to manage high blood pressure through lifestyle changes and medical treatment to reduce the risk of these complications.

High blood pressure increases the risk of hemorrhagic transformation of infarction

HT can be identified in 3–40% of patients with ischemic stroke, depending on the definition used and the characteristics of the cohort studied. The incidence of spontaneous HT ranges from 38% to 71% in autopsy studies and from 13% to 43% in CT studies, whereas the incidence of symptomatic HT is from 0.6% to 20%. The rate of hemorrhagic infarction (HI) is higher than that of parenchymal hematoma (PH). In a large cohort of consecutive patients with acute ischemic stroke, the incidence of HI was about 9%, whereas that of PH was about 3%.

Several factors are associated with an increased risk of HT, many of which are related to inflammation and activation of the immune system. These factors include stroke severity, reperfusion therapy (thrombolysis and thrombectomy), hypertension, hyperglycemia, and age. HT is a dynamic and complex phenomenon, and its pathophysiology is still not entirely clear. However, within seconds to minutes after the onset of cerebral ischemia, the level of ATP decreases substantially, compromising the activity of the Na+-K+ ATPase. This creates a series of cellular and metabolic imbalances that lead to a disruption of the BBB. Ischemia also results in a strong inflammatory response, further distorting normal cerebrovascular anatomy and physiology. The resulting disruption of the BBB and the impairment of the autoregulatory capacity of the cerebral vasculature predispose the brain to blood extravasation when the ischemic tissue is eventually reperfused. Importantly, the degree of anatomical and physiological disruption appears highly dependent on the duration of ischemia.

Thrombolytic treatment with tissue plasminogen activator (tPA) can successfully reperfuse the ischemic brain but increases the rate of HT, thus limiting its use. Recent data suggest that the signaling activities of tPA in the neurovascular unit are responsible for some potentially neurotoxic side effects. Besides its intended role in clot lysis, tPA is also an extracellular protease and signaling molecule in the brain. In particular, tPA mediates matrix remodeling during brain development and plasticity. By interacting with the NMDA-type glutamate receptor, tPA may amplify potentially excitotoxic calcium currents. Furthermore, at certain concentrations, tPA may be vasoactive. Finally, by augmenting matrix metalloproteinase (MMP) dysregulation after stroke, tPA may degrade the extracellular matrix integrity and increase the risks of neurovascular cell death, BBB leakage, edema, and hemorrhage.

At present, effective intervention measures for HT after thrombolytic therapy are limited. Some studies suggest that inhibition of MMP-2 or MMP-9 can protect against HT during the early stage of cerebral ischemia and reperfusion. In particular, it was found that both MMP-2 and MMP-9 are significantly upregulated and activated in the early stage of ischemic reperfusion injury, suggesting that these enzymes are associated with early ischemic brain damage. Therefore, reduction of activity of MMP-2 or MMP-9 can decrease the incidence of HT.

Frequently asked questions